173 related articles for article (PubMed ID: 27108352)
21. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.
Yang GC; Schreiner AM; Sun W
Cytopathology; 2013 Jun; 24(3):185-93. PubMed ID: 22672530
[TBL] [Abstract][Full Text] [Related]
22. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
23. Hürthle cell tumors.
Hillman N; Hardisson D; Herranz L; Martinez Olmos MA; Hernandez Bayo JA; Nistal M; Pallardo LF
Ann Med Interne (Paris); 1997; 148(6):434-9. PubMed ID: 9538377
[TBL] [Abstract][Full Text] [Related]
24. Thyroid implants after surgery and blunt trauma.
Harach HR; Cabrera JA; Williams ED
Ann Diagn Pathol; 2004 Apr; 8(2):61-8. PubMed ID: 15060882
[TBL] [Abstract][Full Text] [Related]
25. [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases].
Janser JC; Pusel J; Rodier JF; Navarrete E; Rodier D
J Chir (Paris); 1989 Nov; 126(11):619-24. PubMed ID: 2685000
[TBL] [Abstract][Full Text] [Related]
26. Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.
Sinno S; Choucair M; Nasrallah M; Wadi L; Jabbour MN; Nassif S
Int J Surg Pathol; 2016 Sep; 24(6):519-24. PubMed ID: 27006301
[TBL] [Abstract][Full Text] [Related]
27. [Clinical experience in Hurthle cell tumors].
Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
[TBL] [Abstract][Full Text] [Related]
28. [Hürthle cells carcinoma. Report of two operated cases and review of the literature].
Pino Rivero V; González Palomino A; Trinidad Ruíz G; Keituqwa Yáñez T; Marcos García M; Pardo Romero G; Pantoja Hernández CG; Blasco Huelva A
An Otorrinolaringol Ibero Am; 2005; 32(5):467-73. PubMed ID: 16318090
[TBL] [Abstract][Full Text] [Related]
29. Molecular Characterization of an Endometrial Endometrioid Adenocarcinoma Metastatic to a Thyroid Hürthle Cell Adenoma Showing Cancerization of Follicles.
Afrogheh AH; Meserve E; Sadow PM; Stephen AE; Nosé V; Berlin S; Faquin WC
Endocr Pathol; 2016 Sep; 27(3):213-9. PubMed ID: 26687112
[TBL] [Abstract][Full Text] [Related]
30. Thyroid Hürthle cell tumors: research of potential markers of malignancy.
Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G
J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382
[TBL] [Abstract][Full Text] [Related]
31. The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience.
Rossi ED; Martini M; Straccia P; Raffaelli M; Pennacchia I; Marrucci E; Lombardi CP; Pontecorvi A; Fadda G
Eur J Endocrinol; 2013 Nov; 169(5):649-55. PubMed ID: 23985131
[TBL] [Abstract][Full Text] [Related]
32. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
33. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
Abu-Alfa AK; Straus FH; Montag AG
Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
[TBL] [Abstract][Full Text] [Related]
34. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathology of well-differentiated thyroid carcinomas.
Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
[TBL] [Abstract][Full Text] [Related]
36. Intrathyroidal oncocytic parathyroid adenoma: a diagnostic pitfall on fine-needle aspiration.
Paker I; Yilmazer D; Yandakci K; Arikok AT; Alper M
Diagn Cytopathol; 2010 Nov; 38(11):833-6. PubMed ID: 20301208
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
38. Hürthle cell thyroid adenoma with an eggshell calcification: sonographic-pathologic correlation.
Lee SK
J Clin Ultrasound; 2014; 42(3):172-5. PubMed ID: 23913794
[TBL] [Abstract][Full Text] [Related]
39. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
McHenry CR; Sandoval BA
Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
[TBL] [Abstract][Full Text] [Related]
40. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
